BN Business News
Add your company to Business Communicator →

Market regulation · 24/07/2002Updated: 10/17/2026 · 1 min read

Amgen Inc. and Immunex Corporation Reach Consent Agreement to Settle Allegations of Unfair Business Practices

Summary

Amgen Inc. and Immunex Corporation have reached a consent agreement to settle allegations of violating Federal law, with the attached analysis outlining the allegations and proposed terms of the settlement. The agreement aims to resolve claims of unfair or deceptive acts or practices, and unfair methods of competition.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Explore insights

Business insights →